Liège, Belgium, 26 June 2015 – Following the press release of 23 June 2015 on the coverage of the base offering throughout the price range, Mithra Pharmaceuticals SA (the “Company” or “Mithra”), a pharmaceutical company focused on women’s health, announces today, in accordance with the possibility provided for in the Offering section of its Prospectus dated 16 June 2015, a narrowing of its price range from between EUR 10.50 and EUR 12.50 to between EUR 11.50 and EUR 12.50 per offered share. The offering, including over-allotment facility, is covered throughout the revised range. The offering period will close on 26 June 2015 at 4:00 pm (CEST).